Skip to content
Open access · CC-BY via OpenAlex

Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets

Teresa Smit, Ronald Anderson, Helen C. Steel, Theresa M. Rossouw, Bernardo Leon Rapoport

Diseases · 2026

Abstract

Background/objectives: Although informative, current insights into the inflammatory nature of colorectal cancer (CRC) have yet to have a meaningful impact on the prevention of, and development of novel therapies for, the treatment of this prevalent and challenging disease. Accordingly, the current study was focused on identifying putative, key, systemic, mostly pro-inflammatory biomarkers of metastatic CRC (mCRC) prognosis and outcome. Methods: Patients with mCRC (n = 38) and matched healthy controls (n = 30) were recruited to the study. A multiplex magnetic bead array system and an ELISA procedure were used to measure the plasma concentrations of selected cytokines (n = 25) and that of C-reactive protein (CRP) by immunonephelometry. Systemic inflammatory indices (n = 5) were derived from the hematological data. Results: Plasma levels of 17/25 of the cytokine biomarkers and CRP were found to be significantly elevated, while the neutrophil/lymphocyte ratio proved to be the most useful of the various inflammatory indices. Subgroup analysis of the data derived from the group of mCRC patients revealed that the intensity of the systemic inflammatory response was mostly unaffected by tumor location, age, gender, and treatment line. The exception was time to progression, with a shorter time (<120 days) being associated with increased levels of IL-6, IL-8 and TNF-α. Hierarchical cluster analysis of the data revealed a possible association with a small group of four cytokines, comprising IL-1β, IL-13, IL-6/CRP and TGF-β1. Conclusions: This study confirms a strong association of established mCRC with cytokine-driven systemic inflammation. Four of these cytokines, IL-1β/IL-13 IL-6/CRP, and TGF-β1, appear prominent and are possibly indicative of novel targetable therapeutic options.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/diseases14050153
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Smit, T., Anderson, R., Steel, H.C., Rossouw, T.M., &amp; Rapoport, B.L. (2026). Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets. <em>Diseases</em>. https://doi.org/10.3390/diseases14050153
Vancouver
Smit T, Anderson R, Steel HC, Rossouw TM, Rapoport BL. Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets. Diseases. 2026. doi:10.3390/diseases14050153.
BibTeX
@article{teresa2026System, title = {Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets}, author = {Teresa Smit and Ronald Anderson and Helen C. Steel and Theresa M. Rossouw and Bernardo Leon Rapoport}, journal = {Diseases}, year = {2026}, doi = {10.3390/diseases14050153}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings